Ac-D-DGla-LI-Cha-C
Ac-D-DGla-LI-Cha-C is a potent HCV protease inhibitor peptide. Ac-D-DGla-LI-Cha-C can be used for the research of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases[1].
Product Specifications
CAS Number
208940-40-3
UNSPSC
12352209
Target
HCV Protease
Type
Peptides
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Cancer; Infection; Metabolic Disease; Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ac-d-dgla-li-cha-c.html
Solubility
H2O
Smiles
OC(C[C@H](NC(C)=O)C(N[C@H](CC(C(O)=O)C(O)=O)C(N[C@@H](CC(C)C)C(N[C@@H]([C@@H](C)CC)C(N[C@H](C(N[C@@H](CS)C(O)=O)=O)CC1CCCCC1)=O)=O)=O)=O)=O
Molecular Formula
C36H58N6O14S
Molecular Weight
830.94
References & Citations
[1]Dorian Bevec, et al. Hcv protease inhibitor and octreotide as therapeutic agents. WO2009033659A1.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
NTRK3 (Neurotrophic Tyrosine Kinase, Receptor, Type 3, TRKC, gp145 (trkC) )
